Breadcrumb AMCP.org Resource Center Publications Letters, Statements & Analysis AMCP Comment on Labeling for Biosimilar and Interchangeable Biosimilar Products AMCP Comment on Labeling for Biosimilar and Interchangeable Biosimilar Products 11/17/23 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page AMCP_Comment_Letter_on_Labeling_of_Biosimilars_11.17.23.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page